Effect of adrenaline on basal and ovine corticotrophin-releasing factor-stimulated ACTH secretion in man
- 1 January 1987
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 112 (1) , 145-150
- https://doi.org/10.1677/joe.0.1120145
Abstract
Six normal male subjects were given, in single blind random order on six separate occasions, i.v. bolus doses of synthetic ovine corticotrophin-releasing factor-41 (oCRF-41; 25 and 50 μg) with and without adrenaline (3 μg/min) i.v. for 150 min, the adrenaline infusions alone and saline placebo. The adrenaline infusions resulted in plasma adrenaline concentrations of 4·33 ± 0·82 (s.e.m.) nmol/l and were associated with an increase in blood glucose, heart rate and systolic blood pressure and a reduction of diastolic blood pressure. Despite these evident biological effects at several sites, there was no stimulation of plasma ACTH or cortisol by adrenaline in comparison with the effect of saline, and no enhancement of the stimulatory effect of either dose of oCRF-41 on ACTH or cortisol secretion. The ACTH response to 50 μg oCRF-41 was greater than that to 25 μg, indicating that the 25 μg dose of oCRF-41 was sub-maximal and capable of further enhancement. As the plasma adrenaline concentrations during the adrenaline infusions reached the upper limit of the physiological range of plasma adrenaline in man, yet failed to enhance the ACTH or cortisol responses to a sub-maximal dose of oCRF-41, we conclude that circulating adrenaline neither exerts a direct stimulatory effect on pituitary corticotrophs nor enhances the effect of CRF under physiological circumstances. The adrenaline infusions attenuated the ACTH and cortisol responses to oCRF-41 and were associated with a transient reduction of basal concentrations of both hormones. J. Endocr. (1987) 112, 145–150This publication has 10 references indexed in Scilit:
- The Role of Opioid Peptides in the Hormonal Responses to Acute Exercise in ManClinical Science, 1984
- Adrenomedullary response to maximal stress in humansThe American Journal of Medicine, 1984
- ADRENERGIC CONTROL OF IMMUNOREACTIVE BETA-ENDORPHIN RELEASE FROM THE PITUITARY OF THE RAT - INVITRO AND INVIVO STUDIES1982
- Adrenergic Mechanisms Involved in the Control of Pituitary-Adrenal Activity in the Rat: A β-Adrenergic Stimulatory MechanismEndocrinology, 1982
- Differential control of β-endorphin/β-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitroLife Sciences, 1980
- Secretion of Dopamine into Hypophysial Portal Blood by Rats Bearing Prolactin-Secreting Tumors or Ectopic Pituitary Glands*Endocrinology, 1979
- Release of Newly Synthesized Dopamine into the Hypophysial Portal Vasculature of the Rat*Endocrinology, 1979
- Perfused Rat Isolated Anterior Pituitary Cell Column as Bioassay for Factor(s) Controlling Release of Adrenocorticotropin: Validation of a TechniqueEndocrinology, 1978
- PLASMA NORADRENALINE AND ADRENALINE CONCENTRATIONS AND DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN PATIENTS WITH SHOCK DUE TO SEPTICEMIA, TRAUMA AND HEMORRHAGE1978
- Effect of Norepinephrine Infusion on Plasma Vasopressin Levels in Normal Human SubjectsJournal of Clinical Endocrinology & Metabolism, 1976